CN Stock MarketDetailed Quotes

600511 China National Medicines Corporation

Watchlist
  • 34.75
  • +0.09+0.26%
Market Closed Apr 30 15:00 CST
26.22BMarket Cap11.97P/E (TTM)

China National Medicines Corporation Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

China National Medicines Corporation Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 26, 2024

Revenue(YoY)

12.12B

+7.98%
EPS(YoY)

0.61

+10.85%
Analyst Rating

Strong Buy

May 4, 2024

China National Medicines Corporation Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 13.505B--
--2024/Q2-- / 14.076B--
Apr 26, 20242024/Q112.122B / 12.237B--
Mar 21, 20242023/Q413.166B / 11.699B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 13.505B--
--2024/Q2-- / 14.076B--
Apr 26, 20242024/Q112.122B / 12.237B--
Mar 21, 20242023/Q413.166B / 11.699B--

China National Medicines Corporation Earnings Reports

  • Sinopharm 2024 First Quarter Report

    Apr 26 00:00

  • 600511_Sinopharm Co., Ltd. _2023_Annual Report

    Mar 21 00:00

  • Summary of Sinopharm's 2023 Annual Report

    Mar 21 00:00

  • 600511_Sinopharm Co., Ltd. _2023_Third Quarter Report

    Oct 25, 2023 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: May 4, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg